1. Home
  2. TKNO vs XPER Comparison

TKNO vs XPER Comparison

Compare TKNO & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • XPER
  • Stock Information
  • Founded
  • TKNO 1996
  • XPER 1990
  • Country
  • TKNO United States
  • XPER United States
  • Employees
  • TKNO N/A
  • XPER 1620
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • XPER Semiconductors
  • Sector
  • TKNO Health Care
  • XPER Technology
  • Exchange
  • TKNO Nasdaq
  • XPER Nasdaq
  • Market Cap
  • TKNO 340.9M
  • XPER 304.4M
  • IPO Year
  • TKNO 2021
  • XPER 2003
  • Fundamental
  • Price
  • TKNO $5.33
  • XPER $6.64
  • Analyst Decision
  • TKNO
  • XPER Strong Buy
  • Analyst Count
  • TKNO 0
  • XPER 2
  • Target Price
  • TKNO N/A
  • XPER $13.50
  • AVG Volume (30 Days)
  • TKNO 370.4K
  • XPER 527.5K
  • Earning Date
  • TKNO 11-06-2025
  • XPER 11-05-2025
  • Dividend Yield
  • TKNO N/A
  • XPER N/A
  • EPS Growth
  • TKNO N/A
  • XPER N/A
  • EPS
  • TKNO N/A
  • XPER N/A
  • Revenue
  • TKNO $38,923,000.00
  • XPER $475,219,000.00
  • Revenue This Year
  • TKNO $9.52
  • XPER N/A
  • Revenue Next Year
  • TKNO $15.20
  • XPER $5.70
  • P/E Ratio
  • TKNO N/A
  • XPER N/A
  • Revenue Growth
  • TKNO 11.40
  • XPER N/A
  • 52 Week Low
  • TKNO $3.94
  • XPER $5.69
  • 52 Week High
  • TKNO $10.37
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 51.65
  • XPER 53.71
  • Support Level
  • TKNO $5.20
  • XPER $6.53
  • Resistance Level
  • TKNO $6.68
  • XPER $6.95
  • Average True Range (ATR)
  • TKNO 0.61
  • XPER 0.23
  • MACD
  • TKNO -0.04
  • XPER 0.04
  • Stochastic Oscillator
  • TKNO 36.29
  • XPER 56.25

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: